The willingness to pay for health improvement under comorbidity ambiguity.
Comorbidity ambiguity
Cost-benefit analysis
Smooth ambiguity model
α-maxmin model
Journal
Journal of health economics
ISSN: 1879-1646
Titre abrégé: J Health Econ
Pays: Netherlands
ID NLM: 8410622
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
02
05
2018
revised:
11
04
2019
accepted:
15
04
2019
pubmed:
29
5
2019
medline:
17
9
2020
entrez:
29
5
2019
Statut:
ppublish
Résumé
Accumulated medical information is necessary to determine comorbidity risk between a primary disease and secondary diseases. However, medical decisions often must be made without conclusive evidence because individuals do not have sufficient information. By introducing ambiguity regarding comorbidities, we describe situations in which individuals face a set of plausible comorbidity risks that determines the correlations between primary and secondary diseases. This study examines the conditions under which the willingness to pay for health improvement is larger with comorbidity ambiguity than without it. This study also examines the effect of changes in ambiguity and ambiguity aversion on the willingness to pay.
Identifiants
pubmed: 31136854
pii: S0167-6296(18)30409-0
doi: 10.1016/j.jhealeco.2019.04.002
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
91-100Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.